Cannbiorx Life Sciences Stock Performance
| ATNFW Stock | USD 0.01 0 34.09% |
CannBioRx Life holds a performance score of 8 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 3.3, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, CannBioRx Life will likely underperform. Use CannBioRx Life treynor ratio, as well as the relationship between the expected short fall and day median price , to analyze future returns on CannBioRx Life.
Risk-Adjusted Performance
8 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in CannBioRx Life Sciences are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal technical and fundamental indicators, CannBioRx Life showed solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 7 M |
CannBioRx |
CannBioRx Life Relative Risk vs. Return Landscape
If you would invest 0.82 in CannBioRx Life Sciences on August 28, 2024 and sell it today you would earn a total of 0.36 from holding CannBioRx Life Sciences or generate 43.9% return on investment over 90 days. CannBioRx Life Sciences is currently producing 2.0351% returns and takes up 19.7267% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than CannBioRx, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
CannBioRx Life Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for CannBioRx Life's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as CannBioRx Life Sciences, and traders can use it to determine the average amount a CannBioRx Life's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1032
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ATNFW | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 19.73 actual daily | 96 96% of assets are less volatile |
Expected Return
| 2.04 actual daily | 40 60% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 8 92% of assets perform better |
Based on monthly moving average CannBioRx Life is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CannBioRx Life by adding it to a well-diversified portfolio.
CannBioRx Life Fundamentals Growth
CannBioRx Stock prices reflect investors' perceptions of the future prospects and financial health of CannBioRx Life, and CannBioRx Life fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CannBioRx Stock performance.
| Return On Equity | -3.99 | ||||
| Return On Asset | -0.63 | ||||
| EBITDA | (22.13 M) | ||||
| Net Income | (19.94 M) | ||||
| Total Debt | 1.05 M | ||||
| Book Value Per Share | (0.24) X | ||||
| Cash Flow From Operations | (10.92 M) | ||||
| Market Capitalization | 250.78 M | ||||
| Total Asset | 5.26 M | ||||
| Retained Earnings | (127.34 M) | ||||
| Working Capital | (1.42 M) | ||||
About CannBioRx Life Performance
Evaluating CannBioRx Life's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if CannBioRx Life has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if CannBioRx Life has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | -2.4 K | -2.3 K | |
| Return On Tangible Assets | (5.48) | (5.75) | |
| Return On Capital Employed | (68.46) | (65.04) | |
| Return On Assets | (3.79) | (3.98) | |
| Return On Equity | 156.07 | 163.87 |
Things to note about CannBioRx Life Sciences performance evaluation
Checking the ongoing alerts about CannBioRx Life for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for CannBioRx Life Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| CannBioRx Life is way too risky over 90 days horizon | |
| CannBioRx Life has some characteristics of a very speculative penny stock | |
| CannBioRx Life appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (19.94 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| CannBioRx Life generates negative cash flow from operations | |
| CannBioRx Life has a poor financial position based on the latest SEC disclosures |
- Analyzing CannBioRx Life's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CannBioRx Life's stock is overvalued or undervalued compared to its peers.
- Examining CannBioRx Life's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CannBioRx Life's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CannBioRx Life's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of CannBioRx Life's stock. These opinions can provide insight into CannBioRx Life's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for CannBioRx Stock Analysis
When running CannBioRx Life's price analysis, check to measure CannBioRx Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CannBioRx Life is operating at the current time. Most of CannBioRx Life's value examination focuses on studying past and present price action to predict the probability of CannBioRx Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CannBioRx Life's price. Additionally, you may evaluate how the addition of CannBioRx Life to your portfolios can decrease your overall portfolio volatility.